Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-7-9
pubmed:abstractText
The pathway for selective serotonergic toxicity of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") is poorly understood, but has been linked to hyperthermia and disturbed energy metabolism. We investigated the dose-dependency and time-course of MDMA-induced perturbations of cerebral glucose metabolism in freely moving rats using rapid sampling microdialysis (every minute) coupled to flow-injection analysis (FIA) with biosensors for glucose and lactate. Blood samples for analysis of glucose and lactate were taken at 30-45 min intervals before and after drug dosing and body temperature was monitored by telemetry. A single dose of MDMA (2-10-20 mg/kg i.v.) evoked a transient increase of interstitial glucose concentrations in striatum (139-223%) with rapid onset and of less than 2h duration, a concomitant but more prolonged lactate increase (>187%) at the highest MDMA dose and no significant depletions of striatal serotonin. Blood glucose and lactate levels were also transiently elevated (163 and 135%) at the highest MDMA doses. The blood glucose rises were significantly related to brain glucose and brain lactate changes. The metabolic perturbations in striatum and the hyperthermic response (+1.1 degrees C) following systemic MDMA treatment were entirely blocked in p-chlorophenylalanine pre-treated rats, indicating that these effects are mediated by endogenous serotonin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0197-0186
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8-15
pubmed:meshHeading
pubmed-meshheading:17475367-Animals, pubmed-meshheading:17475367-Body Temperature, pubmed-meshheading:17475367-Corpus Striatum, pubmed-meshheading:17475367-Dose-Response Relationship, Drug, pubmed-meshheading:17475367-Energy Metabolism, pubmed-meshheading:17475367-Extracellular Fluid, pubmed-meshheading:17475367-Fenclonine, pubmed-meshheading:17475367-Fever, pubmed-meshheading:17475367-Glucose, pubmed-meshheading:17475367-Lactic Acid, pubmed-meshheading:17475367-Male, pubmed-meshheading:17475367-Microdialysis, pubmed-meshheading:17475367-N-Methyl-3,4-methylenedioxyamphetamine, pubmed-meshheading:17475367-Rats, pubmed-meshheading:17475367-Rats, Sprague-Dawley, pubmed-meshheading:17475367-Serotonin, pubmed-meshheading:17475367-Serotonin Agents, pubmed-meshheading:17475367-Serotonin Antagonists, pubmed-meshheading:17475367-Time Factors, pubmed-meshheading:17475367-Wakefulness
pubmed:year
2007
pubmed:articleTitle
Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
pubmed:affiliation
Anatomy & Neurobiology, Institute of Medical Biology, University of Southern Denmark, Winsløwparken 21, DK-5000 Odense C, Denmark. jbgramsbergen@health.sdu.dk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't